top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Diagnosis and Management of Heart Failure
Diagnosis and Management of Heart Failure
Autore Gladysheva Inna P
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (202 p.)
Soggetto topico Cardiovascular medicine
Medicine and Nursing
Soggetto non controllato 24-h ECG monitoring
2D echocardiography
acute myocardial infarction
adverse left ventricular remodeling
angiotensin receptor-neprilysin inhibitor
arteriovenous fistulas
biomarkers
blood biomarkers
cardiac allograft vasculopathy
cardiopulmonary exercise test
cardiovascular disease
chronic heart failure
chronic kidney disease
clinical assessment
congestion
diagnosis
dilated cardiomyopathy
E/e' ratio
echocardiography
edema
ejection fraction
endothelial dysfunction
epicardial fat
fatty liver
fibrosis
fluid management
galectin-3
heart failure
heart failure readmission
heart rate variability
heart transplant
heart transplant rejection
HFrEF
hospitalization predictor
left atrial strain
left ventricle end-diastolic diameter
left ventricle outflow tract velocity-time integral
left ventricular-arterial coupling
longitudinal strain
matrix metalloproteinases
mortality
myocardial infarction
n/a
NT-proBNP
overhydration
pacing parameters
preserved ejection fraction
preserved left ventricular ejection fraction
pulmonary hypertension
reduced left ventricular ejection fraction
risk stratification
sensing parameters
short-term prognosis
soluble ST2
ST-segment elevation myocardial infarction
tissue inhibitors of metalloproteinases
transthoracic echocardiography
type 2 diabetes mellitus
ventilatory inefficiency
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576881803321
Gladysheva Inna P  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Biomarkers for Heart Disease
Novel Biomarkers for Heart Disease
Autore Lichtenauer Michael
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (420 p.)
Soggetto topico Medicine
Soggetto non controllato acute kidney injury
acute myocardial infarction
AMI
aneurysm
aortic disease
aortic regurgitation
atrial fibrillation
atrial myopathy
biomarker
biomarkers
carbohydrate antigen-125
cardiac biomarkers
cardiac intensive care units
cardiac magnetic resonance imaging
cardiometabolic disease
cardiometabolic risks
cardiovascular death
cardiovascular diseases
cardiovascular events
cardiovascular risk
cardiovascular surgery
catestatin
cell adhesion molecule
ceramides
ceruloplasmin
chronic heart failure
chronic kidney disease
circulating cells
circulating miRNAs
CKD
cohort studies
coronary artery disease
CVD
diet quality
echocardiography
ejection fraction
epicardial adipose tissue
epicardial fat
epicardial fat volume
FABP3
fatty acid-binding protein 3
Framingham risk score
GDF-15
GDF8
growth differentiation factor 15 (GDF-15)
H-FABP
healthy eating index
heart failure
heart failure decompensation
heart-type fatty acid-binding protein
heart-type fatty acid-binding protein (H-FABP)
herat failure
HF
HFpEF
HFrEF
hypertension
inflammatory marker
KLF4
left ventricular adverse remodelling
left ventricular ejection fraction
left ventricular systolic function
liver-type fatty-acid-binding protein
long-term outcomes
longitudinal strain
magnetic resonance imaging
magnetic resonance spectroscopy
metabolic syndrome
microRNA
miRNA
mitochondrial DNA (mtDNA)
mitochondrial dysfunction
muscle wasting
myocardial infarction
myocardial triglyceride content
myostatin
n/a
NAFLD
NAFLD fibrosis score
NT-proBNP
NYHA functional class
obesity
older women
operative risk
oxidative stress
PBMCS
Pentraxin-3
platelets
PPCI
pregnancy-associated plasma protein-A
primary prevention
reactive oxygen species (ROS)
renal dysfunction
repeated measurements
risk prediction
risk stratification
saliva
salivary biomarkers
sarcopenia
secondary prevention
SOCE
soluble suppression of tumorigenicity 2 (sST2)
soluble urokinase-type plasminogen activator receptor (suPAR)
sST2
STEMI
STIM1
sudden cardiac death
suPAR
synthetic phenotype
T1 mapping
TGF-β pathway
thyroid-stimulating hormone
troponin
vena contracta area
ventricular arrhythmia
ventricular tachycardia
very low-density lipoprotein
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557546203321
Lichtenauer Michael  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui